LYDIA LOPEZ: Open Payments
NPI 1306916499 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 12 payments from 5 companies in 2025. Trend: 2023 $382 · 2024 $954 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 8 | $307 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Tris Pharma Inc | 1 | $109 |
| Alkermes, Inc. | 1 | $17 |
Products named: Qelbree, CAPLYTA, COBENFY, Onyda XR, VIVITROL.
Industry payments across TX — which companies pay providers there.
